Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Not Confirmed
Not Confirmed
21-23 January, 2025
Not Confirmed
Not Confirmed
22-23 January, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Industry Trade Show
Not Confirmed
21-23 January, 2025
Industry Trade Show
Not Confirmed
22-23 January, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/bms-j-j-bayer-lead-25-000-pharma-layoffs-in-2024-amylyx-fibrogen-kronos-bio-hit-by-trial-failures-cash-crunch
22 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/yoltech-therapeutics-to-initiate-a-clinical-trial-for-yolt-204-a-first-in-class-bone-marrow-targeted-in-vivo-gene-editing-therapy-for--thalassemia-302355739.html
21 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/yoltech-therapeutics-announces-successful-completion-of-dose-escalation-phase-in-phase-i-trial-of-yolt-201-for-attr-302337849.html
27 Aug 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/yoltech-sells-china-rights-cholesterol-gene-editing-therapy-salubris-29m
22 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/yoltech-therapeutics-administers-first-patient-dose-in-iit-of-yolt-203-the-worlds-first-in-vivo-gene-editing-therapy-for-ph1-302228388.html
11 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/first-patient-dosed-in-phase-i-clinical-trial-of-yolt-201-302194779.html
02 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/first-patient-dosed-in-clinical-trial-of-yolt-101-for-the-treatment-of-fh-302105515.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?